Drugs Online |
 |
 | ||
|
Terapress Hytrin |
|
| ||
Drugs Online » Prescription Drugs 15 » Terapress Hytrin Terazosin is used alone or in combination with other drugs to treat high blood pressure. It works by relaxing blood vessels so blood can flow more easily. Lowering high blood pressure helps prevent strokes heart attacks and kidney problems.This medication is also used to treat an enlarged prostate (benign prostatic hyperplasia or BPH) in men. Terazosin does not shrink the prostate but it helps relax the prostate and bladder neck muscles to improve urine flow and emptying of the bladder. It also reduces other symptoms such as excessive urination at night. Buy Terapress Hytrin and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About Terapress Hytrin: Product Type: Prescription Drugs 15 Terapress (Hytrin Generic Terazosin) Terapress (Hytrin Generic Terazosin) Hytrin Generic Terazosin 2mg Hytrin Generic Terazosin Terapress
View more Prescription Drugs 15 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
